Search

Searching with a thematic focus on Trade Policy, Intellectual Property Rights

Showing 261-270 of 420 results

Pages

• Document

  Traditional knowledge of biodiversity in Asia-Pacific: problems of piracy & protection

  GRAIN, 2002

  This report examines issues surrounding traditional knowledge of biological resources in the Asia - Pacific region particularly in the context of increased pressure on communities and governments to commoditise and privatise biodiversity.
• Document

  CIPR final report: integrating intellectual property rights and development policy

  Commission on Intellectual Property Rights, 2002

  This, the final report of the Commission on Intellectual Property Rights set up by the UK government in 2001 and consisting of members representing a range of views on all aspects of IPRs.The Commission was asked to consider:how national IPR regimes could best be designed to benefit developing countries within the context of international agreements, including TRIPS;how the internat
• Document

  Intellectual property and the availability of pharmaceuticals in poor countries

  National Bureau of Economic Research, USA, 2002

  This paper examines arguments in favor and against the strengthening of worldwide patent protection in relation to pharmaceuticals. It emphasizes that these new pharmaceutical patents promise benefits and costs that differ with the characteristics of diseases. Some diseases primarily affect poor countries.
• Document

  Amended patents act and access to medicines after Doha

  International Environmental Law Research Centre, 2002

  This article examines the ammended India Patents Act which passed into law shortly after the Doha declaration on TRIPS and access to medicines.
• Document

  Genetically modified crops in Africa: implications for small farmers

  GRAIN, 2002

  This briefing looks at the push to bring genetically modified (GM) crops and technologies to Africa and shows the implications for farmers in Eastern and Southern Africa. What will the introduction of GM crops mean for Africa and its small farmers in particular?
• Document

  Issues linked to Convention on Biological Diversity in the WTO negotiations implementing Doha mandates.

  Center for International Environmental Law, 2002

  This document analyses the content of TRIPS and CBD related mandates contained in the Ministerial texts approved at Doha. It aims at providing developing countries with suggestions for common action in the relevant WTO bodies.
• Document

  Intellectual property rights in African agriculture: implications for small farmers

  GRAIN, 2002

  This paper looks at the choice facing African policy-makers over which of two opposing models of agricultural R&D to choose to support. One is driven by multinational companies in the North and relies upon private monopolies and genetically modified crops.
• Document

  World Bank pharmaceuticals discussion paper

  World Bank Publications, 2000

  There is a profound gap between the benefit that pharmaceuticals have to offer and the reality that for millions of people - particularly poor and disadvantaged people - medicines are unavailable, unaffordable, unsafe or improperly used.
• Document

  Beyond philanthropy: the pharmaceutical industry, corporate social responsibility and the developing world

  Save the Children Fund, 2002

  This paper argues that responsible pharmaceutical companies must have policies on access to treatment for developing countries which include the five priorities of: pricing; patents; joint public private initiatives (JPPIs); research and development (R&D); and the appropriate use of drugs.
• Document

  Agricultural biotechnology: technology policy brief

  United Nations University Institute for New technologies, 2002

  This is a collection of articles making up the UNU/INTECH technology policy brief on the subject of agricultural biotechnology.

Pages